Scilex Holding Company share price logo

Scilex Holding Company

NASDAQ: SCLX

$2.36

-0.11

(-4.45%)

Live

as on

Scilex Holding Company Stock Performance

as on October 24, 2026 at 6:08 am IST

  • Day's Low

    Day's High

    $2.27
    $2.48
    downward going graph

    3.81%

    Downside

    5.08%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.45
    $27.00
    downward going graph

    -3.77%

    Downside

    1044.07%

    Upside

    downward going graph

Scilex Holding Company share price movements today

Previous Close
$2.47
Open
$2.45
Volume
257.0K
Market Cap
$18.0M
Day's Low - High
$2.27 - $2.48
52 Week Low - High
$2.45 - $27.00

Scilex Holding Company Historical Returns

1 Month Return
-51.57 %
3 Month Return
-66.58 %
1 Year Return
-83.07 %
3 Year Return
-95.87 %
5 Year Return
0 %

Scilex Holding Company Stock Fundamentals & Key Indicators

Check Scilex Holding Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.0M

EPS (TTM)

-64.88

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.04

Industry PE ratio

-11.13

PEG Ratio

0.00

EBITDA

-360.6M

Revenue (TTM)

31.6M

Profit Margin

41.49%

Return On Equity TTM

189.81%

Scilex Holding Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Scilex Holding Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Scilex Holding Company image
Scilex Holding Company
Buy$18.0MNA-0.0441.49%0.00%
Eli Lilly & Co image
Eli Lilly & Co
StrongBuy$1.2T436.08%42.5183.40%0.53%
AbbVie image
AbbVie
StrongBuy$510.8B161.31%80.2171.48%2.43%
Johnson & Johnson image
Johnson & Johnson
Buy$621.2B63.46%39.0868.81%2.05%
Merck & Company image
Merck & Company
Buy$365.9B81.44%118.9875.38%2.27%
See all

Stock Returns calculator for Scilex Holding Company Stock including INR - Dollar returns

The Scilex Holding Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Scilex Holding Company investment value today

Current value as on today

₹17,495

Returns

-₹82,505

(-82.5%)

Returns from Scilex Holding Company Stock

-₹83,825 (-83.82%)

Dollar Impact

₹1,320 (+1.32%)

Analyst Recommendation on Scilex Holding Company Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Scilex Holding Company. Average target price of $490

Scilex Holding Company Share Price Target

Get share price movements and forecasts by analysts on Scilex Holding Company.

What analysts predicted

99.52%UPSIDE

Target Price

$490

Current Price

$2.36

Analyzed by

8 Analysts

Target

$490.00

Scilex Holding Company target price $490, a slight upside of 99.52% compared to current price of $2.36. According to 8 analysts rating.

Indian Investors' Interest in Scilex Holding Company Stock

Search interest for Scilex Holding Company Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-17% versus previous 30 day period

Scilex Holding Company Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
10
16
14
14
5
9
10
4
8
7
Gross Profit
7
11
10
10
3
6
7
0
4
1
Operating Income
-19
-15
-19
-28
-27
-20
-186
-37
-32
-29
EBITDA
-22
-36
-2
-5
-22
-40
-253
-41
-39
-26
Interest Expense
0
0
0
0
2
2
2
3
3
6
Depreciation
1
1
1
1
1
1
1
1
2
2
Income Before Tax
-24
-37
-4
-6
-26
-44
-257
-46
-45
-114
Income Tax Expense
-
-
-
0
-
0
0
0
-
0
Net Income
-24
-37
-4
-6
-26
-86
-257
-33
-43
-113
Net Profit Margin
64.72%
73.18%
73.90%
68.52%
72.34%
66.94%
68.48%
12.33%
48.37%
14.73%

Scilex Holding Company Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
23
31
38
46
56
30
Gross Profit
21
27
27
31
39
15
Operating Income
-35
-35
-50
-105
-83
-272
EBITDA
-31
-72
-9
-109
-66
-357
Interest Expense
13
11
9
1
1
11
Depreciation
3
3
3
4
4
4
Income Before Tax
-47
-88
-23
-114
-72
-374
Income Tax Expense
0
0
0
0
0
0
Net Income
-47
-88
-23
-114
-72
-358
Net Profit Margin
90.88%
88.40%
71.61%
66.45%
70.51%
49.68%

Scilex Holding Company Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-24
-37
-4
-6
-26
-44
-257
-33
-45
-114
Operating Cash Flow
9
2
5
2
6
7
8
-17
-1
-6
Investing Cash Flow
0
0
-2
0
0
0
0
4
-9
8
Financing Cash Flow
-11
4
-4
-7
-3
-8
-11
17
9
-4
Change in Cash
-1
6
-1
-4
2
-1
-3
4
-1
-2

Scilex Holding Company Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-47
-88
-23
-114
-72
-358
Operating Cash Flow
-31
-28
-21
-20
19
3
Investing Cash Flow
0
-
-2
0
-2
4
Financing Cash Flow
-19
28
21
23
-18
-5
Change in Cash
-50
0
-2
2
-1
1

Global Institutional Holdings in Scilex Holding Company

Check out the Institutions with significant holdings in Scilex Holding Company.

Funds
Holdings
Vanguard
4.18%
VANGUARD INDEX FUNDS
3.60%
Northern Funds
0.47%
iShares
0.34%
Victory Portfolios III
0.12%
See all

Scilex Holding Company News & Key Events

    Insights on Scilex Holding Company

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Eli Lilly & Co. has given 42.5% return, outperforming this stock by 138.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Merck & Co., Inc. has given 68.9% return, outperforming this stock by 152.0%

    • imgNEGATIVE IMPACT

      Price Dip

      img

      In the last 7 days, SCLX stock has moved down by -12.7%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 3 quarters, -33.11M → -113.50M (in $), with an average decrease of 96.5% per quarter

    • imgNEGATIVE IMPACT

      Revenue Fall

      img

      Revenue is down for the last 2 quarters, 8.61M → 7.64M (in $), with an average decrease of 11.3% per quarter

    About Scilex Holding Company

    Scilex Holding Company is a biopharmaceutical enterprise that specializes in the development and market introduction of non-opioid therapies designed to alleviate both acute and chronic pain. Its primary marketed offering is ZTlido 1.8%, a topical prescription formulation of lidocaine specifically engineered to mitigate neuropathic discomfort associated with post-herpetic neuralgia, a condition characterized by persistent nerve pain following shingles. Beyond this, the company's development pipeline includes SP-102, a viscous gel corticosteroid for epidural administration, currently undergoing Phase III trials for lumbosacral radicular pain. Another candidate, SP-103, is progressing through Phase II trials for managing low back pain. Furthermore, SP-104, a novel, low-dose, delayed-release naltrexone hydrochloride formulation, has successfully concluded Phase I clinical testing for the treatment of fibromyalgia. Its corporate offices are situated in Palo Alto, California. Scilex Holding Company operates as a subsidiary of Sorrento Therapeutics, Inc.
    OrganisationScilex Holding Company
    Headquarters960 San Antonio Road, Palo Alto, CA, 94303, US
    IndustryDrug Manufacturers - General
    CEOHenry H. Ji

    Key Management of Scilex Holding Company

    Name

    Title

    Mr. Stephen Ma

    Senior VP, CFO, COO, Corporate Secretary & Director

    Dr. Suketu D. Desai Ph.D.

    Interim Chief Technical Officer & Senior VP

    Ms. Gigi DeGuzman

    VP & Chief People Officer

    Mr. Suresh K. Khemani

    Senior VP, Chief Commercial Officer & GM of Scilex Pharma

    Dr. Dmitri V. Lissin M.D.

    Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer

    Dr. Henry H. Ji Ph.D.

    CEO, President & Executive Chairman

    FAQs

    What is Scilex Holding Company share price today?

    Scilex Holding Company share price today is $2.36 as on . Scilex Holding Company share today touched a day high of $2.48 and a low of $2.27.

    What is the 52 week high and 52 week low for Scilex Holding Company share?

    Scilex Holding Company share touched a 52 week high of $27.00 on and a 52 week low of $2.45 on . Scilex Holding Company stock price today i.e. is trending at $2.36,which is 91.26% down from its 52 week high and -3.63% up from its 52 week low.

    What is Scilex Holding Company's market capitalisation today?

    Scilex Holding Company market capitalisation is $0.00T as on .

    How to invest in Scilex Holding Company Stock (SCLX) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Scilex Holding Company on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy Scilex Holding Company Stock (SCLX) from India?

    Indian investors can start investing in Scilex Holding Company (SCLX) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.40 in Scilex Holding Company stock (as per the Rupee-Dollar exchange rate as on ). Based on Scilex Holding Company share’s latest price of $2.36 as on October 24, 2026 at 12:38 am IST, you will get 4.2373 shares of Scilex Holding Company. Learn more about fractional shares .